Marie Christine Roesch, Lea Sophie Lütje, Nils Gilbert, Axel Stuart Merseburger, Daniar Osmonov
{"title":"[泌尿肿瘤临床试验中性别/性别特异性差异]。","authors":"Marie Christine Roesch, Lea Sophie Lütje, Nils Gilbert, Axel Stuart Merseburger, Daniar Osmonov","doi":"10.1055/a-2510-9757","DOIUrl":null,"url":null,"abstract":"<p><p>Subgroup analyses in clinical trials sometimes reveal gender-/sex-dependent differences in cancer outcomes. However, drug approvals are rarely restricted to a specific sex or gender, and recommendations regarding dosage are rarely tailored accordingly. Furthermore, discrepancies exist between the gender-/sex-dependent enrollment rates in clinical trials and real-world incidence or mortality rates. This article highlights gender-/sex differences in clinical trials in uro-oncology.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"131-134"},"PeriodicalIF":0.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Gender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology].\",\"authors\":\"Marie Christine Roesch, Lea Sophie Lütje, Nils Gilbert, Axel Stuart Merseburger, Daniar Osmonov\",\"doi\":\"10.1055/a-2510-9757\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Subgroup analyses in clinical trials sometimes reveal gender-/sex-dependent differences in cancer outcomes. However, drug approvals are rarely restricted to a specific sex or gender, and recommendations regarding dosage are rarely tailored accordingly. Furthermore, discrepancies exist between the gender-/sex-dependent enrollment rates in clinical trials and real-world incidence or mortality rates. This article highlights gender-/sex differences in clinical trials in uro-oncology.</p>\",\"PeriodicalId\":7513,\"journal\":{\"name\":\"Aktuelle Urologie\",\"volume\":\" \",\"pages\":\"131-134\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aktuelle Urologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2510-9757\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aktuelle Urologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2510-9757","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
[Gender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology].
Subgroup analyses in clinical trials sometimes reveal gender-/sex-dependent differences in cancer outcomes. However, drug approvals are rarely restricted to a specific sex or gender, and recommendations regarding dosage are rarely tailored accordingly. Furthermore, discrepancies exist between the gender-/sex-dependent enrollment rates in clinical trials and real-world incidence or mortality rates. This article highlights gender-/sex differences in clinical trials in uro-oncology.
期刊介绍:
Die entscheidenden Ergebnisse der internationalen Forschung – für Sie auf den Punkt zusammengefasst und kritisch kommentiert
Übersichtsarbeiten zu den maßgeblichen Themen der täglichen Praxis
Auf dem Laufenden über die klinische Forschung durch interessante Originalien
CME-Punkte sammeln mit der Rubrik "Operative Techniken"
In jeder Ausgabe: Techniken wichtiger Standard-OPs – Schritt für Schritt
Erstklassige OP-Skizzen mit verständlichen Erläuterungen